Amyloid-β peptide aggregation and the influence of carbon nanoparticles

被引:16
|
作者
Xi, Wen-Hui [1 ]
Wei, Guang-Hong [1 ]
机构
[1] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Key Lab Computat Phys Sci,Minist Educ, Shanghai 200433, Peoples R China
基金
中国国家自然科学基金;
关键词
Amyloid-beta; oligomerization; carbon nanoparticles; molecular dynamics; MOLECULAR-DYNAMICS SIMULATIONS; ALZHEIMERS-DISEASE; PROTEIN AGGREGATION; FULL-LENGTH; WILD-TYPE; EXPERIMENTAL CONSTRAINTS; A-BETA(16-22) PEPTIDES; COMPUTER-SIMULATIONS; A-BETA(1-42) MONOMER; PARKINSONS-DISEASE;
D O I
10.1088/1674-1056/25/1/018704
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
Soluble peptides or proteins can self-aggregate into insoluble, ordered amyloid fibrils under appropriate conditions. These amyloid aggregates are the hallmarks of several human diseases ranging from neurodegenerative disorders to systemic amyloidoses. In this review, we first introduce the common structural features of amyloid fibrils and the amyloid fibrillation kinetics determined from experimental studies. Then, we discuss the structural models of Alzheimer's amyloid-beta (A beta) fibrils derived from solid-state nuclear magnetic resonance spectroscopy. On the computational side, molecular dynamics simulations can provide atomic details of structures and the underlying oligomerization mechanisms. We finally summarize recent progress in atomistic simulation studies on the oligomerization of A beta (including full-length A beta and its fragments) and the influence of carbon nanoparticles.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Amyloid-β peptide aggregation and the influence of carbon nanoparticles
    郗文辉
    韦广红
    Chinese Physics B, 2016, (01) : 328 - 336
  • [2] Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study
    Zou, Yu
    Qian, Zhenyu
    Chen, Yujie
    Qian, Hongsheng
    Wei, Guanghong
    Zhang, Qingwen
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (03): : 1585 - 1594
  • [3] Key Residue for Aggregation of Amyloid-β Peptides
    Itoh, Satoru G.
    Yagi-Utsumi, Maho
    Kato, Koichi
    Okumura, Hisashi
    ACS CHEMICAL NEUROSCIENCE, 2022, 13 (22): : 3139 - 3151
  • [4] Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
    Braun, Gabriel A.
    Dear, Alexander J.
    Sanagavarapu, Kalyani
    Zetterberg, Henrik
    Linse, Sara
    CHEMICAL SCIENCE, 2022, 13 (08) : 2423 - 2439
  • [5] RRY Inhibits Amyloid-β1-42 Peptide Aggregation and Neurotoxicity
    Sun, Xicui
    Duan, Songwei
    Cao, Anna
    Villagomez, Bryan
    Lin, Runxuan
    Chen, Hongxia
    Pi, Liya
    Ren, Bin
    Chen, Rong
    Chen, Minjie
    Ying, Zhekang
    Fang, Shenyun
    Cao, Qi
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 479 - 495
  • [6] Influence of Zeolites on Amyloid-β Aggregation
    Lucas, Michael J.
    Keitz, Benjamin K.
    LANGMUIR, 2018, 34 (33) : 9789 - 9797
  • [7] Amyloid-β aggregation
    Finder, Verena H.
    Glockshuber, Rudi
    NEURODEGENERATIVE DISEASES, 2007, 4 (01) : 13 - 27
  • [8] Surface Plasmon Resonance Based Biosensors for Exploring the Influence of Alkaloids on Aggregation of Amyloid-β Peptide
    Krazinski, Bartlomiej Emil
    Radecki, Jerzy
    Radecka, Hanna
    SENSORS, 2011, 11 (04): : 4030 - 4042
  • [9] Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-β peptide
    Brambilla, Davide
    Souguir, Hayfa
    Nicolas, Julien
    Mackiewicz, Nicolas
    Verpillot, Romain
    Le Droumaguet, Benjamin
    Taverna, Myriam
    Couvreur, Patrick
    Andrieux, Karine
    JOURNAL OF BIOTECHNOLOGY, 2011, 156 (04) : 338 - 340
  • [10] Amyloid-β Aggregation with Gold Nanoparticles on Brain Lipid Bilayer
    Lee, Hyojin
    Kim, Yuna
    Park, Anna
    Nam, Jwa-Min
    SMALL, 2014, 10 (09) : 1779 - 1789